In the COSMIC database as well, well-differentiated indolent pancreatic neuroendocrine tumors, with a proliferation rate < 3% Ki-67 [36], carry a ~20% ARID1A mutation rate, much higher than 5.35% aggressive PDAC. This evidence concerns the gene ARID1A and pancreatic neuroendocrine tumor.